发现BRAF突变是好还是坏？ - Suppr

Suppr

超能文献

Is it good or bad to find a BRAF mutation?

作者信息

Flaherty Keith T

出版信息

J Clin Oncol. 2011 Apr 1;29(10):1229-30. doi: 10.1200/JCO.2010.34.0497. Epub 2011 Feb 22.

DOI:10.1200/JCO.2010.34.0497

PMID:21343552

Abstract

摘要

相似文献

Is it good or bad to find a BRAF mutation?发现BRAF突变是好还是坏？

J Clin Oncol. 2011 Apr 1;29(10):1229-30. doi: 10.1200/JCO.2010.34.0497. Epub 2011 Feb 22.

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.致癌 BRAF 在转移性黑色素瘤中的预后和临床病理关联。

J Clin Oncol. 2011 Apr 1;29(10):1239-46. doi: 10.1200/JCO.2010.32.4327. Epub 2011 Feb 22.

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.色瑞替尼联合达卡巴嗪对比安慰剂联合达卡巴嗪作为 BRAF 突变型转移性黑色素瘤的一线治疗：一项 2 期、双盲、随机研究。

Lancet Oncol. 2013 Jul;14(8):733-40. doi: 10.1016/S1470-2045(13)70237-7. Epub 2013 Jun 2.

BRAF inhibitors: research accelerates in wake of positive findings.BRAF抑制剂：阳性结果促使研究加速推进。

J Natl Cancer Inst. 2010 Feb 24;102(4):214-5. doi: 10.1093/jnci/djq037. Epub 2010 Feb 9.

Complete Cytologic Remission of V600E BRAF-Mutant Melanoma-Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib.使用达拉非尼治疗后，V600E BRAF突变型黑色素瘤相关软脑膜癌病实现完全细胞学缓解。

J Clin Oncol. 2015 Oct 1;33(28):e109-11. doi: 10.1200/JCO.2013.48.7298. Epub 2014 Apr 14.

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.获得性BRAF抑制剂耐药性：耐药机制的谱、频率、临床行为及表型关联的多中心荟萃分析

Eur J Cancer. 2015 Dec;51(18):2792-9. doi: 10.1016/j.ejca.2015.08.022. Epub 2015 Nov 19.

[Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma].[选择性阻断突变型BRAF可使转移性黑色素瘤患者获得生存获益]

J Dtsch Dermatol Ges. 2011 Apr;9(4):340. doi: 10.1111/j.1610-0387.2011.07653.x.

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.甲磺酸伊马替尼治疗伴有 c-Kit 突变或扩增的转移性黑色素瘤患者的 II 期、开放标签、单臂试验。

J Clin Oncol. 2011 Jul 20;29(21):2904-9. doi: 10.1200/JCO.2010.33.9275. Epub 2011 Jun 20.

Vemurafenib for BRAF V600 mutated advanced melanoma: results of treatment beyond progression.维莫非尼治疗BRAF V600突变的晚期黑色素瘤：疾病进展后的治疗结果

Eur J Cancer. 2015 Mar;51(5):642-52. doi: 10.1016/j.ejca.2015.01.009. Epub 2015 Feb 15.

A new standard of care for metastatic melanoma?转移性黑色素瘤的一种新的护理标准？

Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71138-6. Epub 2014 Nov 21.

引用本文的文献

Impact of initial stage on metastatic melanoma survival.初始阶段对转移性黑色素瘤生存的影响。

Melanoma Res. 2019 Jun;29(3):281-288. doi: 10.1097/CMR.0000000000000526.

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.采用免疫疗法和联合疗法克服转移性黑色素瘤对靶向治疗的耐药性。

Oncotarget. 2017 Jun 16;8(43):75675-75686. doi: 10.18632/oncotarget.18523. eCollection 2017 Sep 26.

The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence.BRAF V600 抑制剂在晚期皮肤黑色素瘤中的应用潜力：原理与最新证据。

Ther Adv Med Oncol. 2012 Mar;4(2):61-73. doi: 10.1177/1758834011432949.

Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities.转移性皮肤黑色素瘤的新型治疗方法和紧急毒性的处理。

Clin Med Insights Oncol. 2012;6:53-66. doi: 10.4137/CMO.S5855. Epub 2012 Jan 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验